Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
novartis
3
×
boston blog main
boston top stories
cancer immunotherapy
clinical trials
gilead sciences
investing
national top stories
san francisco blog main
adaptimmune
adaptive tcr
amplyx pharmaceuticals
antibiotics
antifungal
arsenalbio
bessemer venture partners
boston
brigham and women’s hospital
cancer
candida
car-t chimeric antigen receptor
car-t immunotherapy
cell therapy
computational biology
david southwell
deals
drug development
drug resistance
euclidean capital
gene editing
ginkgo bioworks
gv
harvard medical school
harvard university
immunotherapy
ken drazan
kleiner perkins
What
immune
3
×
patients
3
×
better
cancer
cell
therapies
acquired
amplyx
arsenalbio
cells
coax
compromised
deal
despite
destroy
drug
drugs
effective
fight
infections
inks
lands
launches
life
new
novartis
patient’s
pharmaceuticals
programmable
progress
receptor
recognize
safer
systems
testing
threatening
tinkering
treatments
tscan
type
Language
unset
unknown
Current search:
immune
×
patients
×
novartis
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}